Updated:
Biomark Capital
Biomark Capital is a Greenwich-based asset manager focused on early-stage venture investments.
Biomark Capital
Biomark Capital invests in early, mid, and late-stage life science companies. The firm focuses on companies with novel approaches to diagnostics, therapeutics, medical devices, and digital health. Biomark has made 30 investments, including a Series A investment in Naluri on June 09, 2021, and has facilitated 7 portfolio exits, including Strand Life Sciences on September 03, 2021.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Greenwich
Corporate office
Greenwich, United States
Sector focus
Frequently asked questions
What stages does Biomark Capital target?
The firm lists coverage of early-stage seed, start-up, expansion, and general venture.
Where is Biomark Capital based?
Headquarters are in Greenwich, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: